ACPE UAN #: 0233-0000-19-015-H04-P
Release Date: March 25, 2019
Expiration Date: March 25, 2022
Activity Type: Knowledge-based
Contact Hours: 1
Activity Fee: Member: $15 Non-Member: $30
Target Audience: Pharmacists who practice in managed care settings.
Gene therapy techniques offer potential breakthroughs for patients with serious health conditions. They also are associated with significant short-term costs yet hold the promise of long-term savings if they deliver durable benefits such as reduced mortality and improved health and quality of life, which can lead to lower health care costs, improved productivity and reduced disability. Thus, gene therapy raises questions about how costs are managed and distributed across systems and payers. Innovative and novel financing and reimbursement strategies may be needed to support sustainable patient access to these new treatments. During this session, participants will explore managed care and provider strategies for addressing gene therapy.
At the completion of this activity, participants should be able to:
- Explain the short-term and long-term financial impacts associated with gene therapy.
- Discuss managed care strategies for addressing issues posed by gene therapy, including formulary considerations.
- Describe innovative and novel payment strategies that may be used to support access to gene therapy.
- Discuss learnings that have emerged from the development of payment models for the use of gene therapy using real-world examples.
Schedule of Educational Activity
This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Specialty Connect 2019.
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Statement of Commercial Support
This educational activity is supported by independent educational grants from AveXis Inc., Genzyme Corporation, Pfizer and Sarepta Therapeutics.
Clifford Goodman, PhD | Senior Vice President & Director | Lewin Center for Comparative Effectiveness Research | Falls Church, Virginia.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-19-015-H04-P||1 Contact Hour||March 25, 2019 - March 25, 2022|